We use cookies to ensure that the website works as intended and to collect statistics on its use so that we can improve your web site experience.


Aker BioMarine lists on Oslo Børs

Back to news

Euronext today congratulates Aker BioMarine on its transfer from Euronext Growth to Oslo Børs (ticker code: AKBM).


Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, and was listed on Euronext Growth in July 2020.


Matts Johansen, CEO of Aker BioMarine, said: “This is an important day in the history of Aker BioMarine. Thanks to the dedication, the grinding through and the enormous effort from our team, we are now reaching yet another milestone for the company. Listed on the Oslo Stock Exchange main market, we have an even better foundation to make it possible to reach our goals when it comes to growing and developing the company in the years to come. We are going to consolidate our position as a biotech innovator while increasing activity significantly. At the same time we shall deliver on our mission to improve human and planetary health.”


Welcome: Øivind Amundsen, President and CEO of Oslo Børs and employees, rang the bell during a virtual ceremony this morning to celebrate the transfer of Aker BioMarine from Euronext Growth to Oslo Børs.

CONTACTS Aker BioMarine
Martin Stenshall, VP Investor relations +47 47 33 83 31 martin.stenshall@akerbiomarine.com

Katrin Berntsen, Director Communications +47 92 05 45 70katrin.berntsen@akerbiomarine.com

CONTACTS media - mediateam@euronext.com
Press office (Oslo): +47 22 34 17 34 oslopressoffice@euronext.com

About Aker BioMarine

Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, developing krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world. The company is dedicated to improving human and planetary Health.

About Euronext
Euronext is the leading pan-European market infrastructure, connecting local economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, the Netherlands, Norway and Portugal. With close to 1,500 listed issuers worth €4.9 trillion in market capitalisation as of end March 2021, it has an unmatched blue chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates Euronext Growth® and Euronext Access®, simplifying access to listing for SMEs. Euronext provides custody and settlement services through central securities depositories in Denmark, Norway and Portugal.
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).